Literature DB >> 18242011

Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.

Marina Tshuikina1, Kenneth Nilsson, Fredrik Oberg.   

Abstract

Epigenetic modifications are critical for regulating many different aspects of normal cell biology and tumourigenesis. Gene expression may be epigenetically silenced by DNA-methylation and histone modifications, resulting in remodelling of chromatin into a repressed state. We performed DNA-methylation analysis of the ICSBP/IRF8 gene, a member of the IRF family of transcriptional regulators expressed in monocytic and lymphocytic cells, in human monoblastic U-937 cells. We found complete methylation of all 39 CpG positions located in a 308 bp sequence encompassing the proximal promoter and transcriptional start site of the ICSBP/IRF8 gene. However, strikingly, the ICSBP/IRF8 gene is still expressed. Chromatin Immuno-precipitation (ChIP) showed that RNA-Polymerase II was present at the major transcriptional start site. Investigating the histone modifications across the ICSBP/IRF8 gene we found the positive histone marks H3K9ac and H3K4me3 to be enriched at the promoter, whereas the level of H3K9me3 was low. This suggests that an active chromatin structure, indicated by histone H3 modifications and enrichment for RNA Pol II, can over-ride the silencing effect of DNA-methylation at the promoter, thereby permitting transcription of the ICSBP/IRF8 gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242011     DOI: 10.1016/j.gene.2007.12.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches.

Authors:  Elena Shumay; Joanna S Fowler
Journal:  Epigenetics       Date:  2010-05-05       Impact factor: 4.528

2.  IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.

Authors:  Xiaolin Hu; Dafeng Yang; Mary Zimmerman; Feiyan Liu; Jine Yang; Swati Kannan; Andreas Burchert; Zdzislaw Szulc; Alicja Bielawska; Keiko Ozato; Kapil Bhalla; Kebin Liu
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

3.  The histone modifications governing TFF1 transcription mediated by estrogen receptor.

Authors:  Yanyan Li; Luyang Sun; Yu Zhang; Dandan Wang; Feng Wang; Jing Liang; Bin Gui; Yongfeng Shang
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

4.  DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines.

Authors:  Sayaka Ichihara; Ryota Kikuchi; Hiroyuki Kusuhara; Satoki Imai; Kazuya Maeda; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2010-02-04       Impact factor: 4.200

5.  IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression.

Authors:  Dafeng Yang; Suizhao Wang; Craig Brooks; Zheng Dong; Patricia V Schoenlein; Vijay Kumar; Xinshou Ouyang; Huabao Xiong; Guy Lahat; Andrea Hayes-Jordan; Alexander Lazar; Raphael Pollock; Dina Lev; Kebin Liu
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

6.  The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

Authors:  Shuvomoy Banerjee; Jie Lu; Qiliang Cai; Abhik Saha; Hem Chandra Jha; Richard Kuo Dzeng; Erle S Robertson
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.